|
Educational Webinar Series
Controversies in the Use of Procalcitonin to Diagnose Sepsis LISTEN NOW |
|
|
Educational Podcast Series
Episode 13 - Procalcitonin Versus Lactate: The Pros and Cons of These Two Indicators of Sepsis LISTEN NOW |
Second to heart attacks, sepsis is the leading cause of death in the intensive care unit. As many as 750,000 patients progress into severe sepsis each year in U.S. hospitals, and approximately 200,000 of these patients do not survive.*
Sepsis can be extremely difficult to diagnose because its primary symptoms mimic the symptoms of several other critical care conditions, including myocardial infarction, pneumonia, pulmonary embolism and other high-morbidity conditions. And because of the aggressive nature of sepsis, diagnosing and initiating treatment of this infection needs to happen as soon as possible. Access to specific information may increase the accuracy of sepsis diagnostics during the critical early stages.
This site was developed to increase awareness and share knowledge related to the use of Procalcitonin and other testing techniques and systems that can be used in diagnosing, treating and managing sepsis.
*Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
With Sepsis, Early Recognition & Diagnosis is the Best Clinical StrategySepsis Solutions will be highlighted at New York Meeting of the American Society of Microbiology Read More |
Sepsis Trends, from the Front Lines of Critical CareEmerging trends that surround sepsis severity, diagnosis and treatment from the perspective of a critical care professional. Read More |